Formulation White Papers & Case Studies
-
Predicting Performance Of Lotions Through Rheological Characterization
5/6/2026
Rheological testing shows how small formulation differences influence spreading, flow, and feel during use. With minimal sample volumes, these methods connect lab measurements to real‑world performance.
-
Rheology Is An Accurate Predictor Of Pharmaceutical Lotion Stability
5/6/2026
Rheological creep testing provides a rapid way to predict pharmaceutical lotion stability by linking steady-state viscosity to particle settling behavior, enabling reliable shelf-life estimates.
-
Mechanochemistry- Enabled Solid-State Stress Testing
5/6/2026
Discover how solvent‑free, solid‑state stress testing speeds degradation studies, yields realistic impurity profiles, and provides earlier, material‑efficient insight into drug stability and risk.
-
The Importance Of Polymorph Screenings
5/6/2026
Discover how systematic polymorph screening reduces development risk, safeguards product performance, and enables confident solid‑form selection across the drug development lifecycle.
-
Deciphering Nanoparticle Properties With AF4
5/6/2026
Discover how risk‑based, phase‑appropriate synthesis enables safe, efficient production of highly potent compounds while balancing speed, worker safety, and regulatory readiness in early development.
-
Drug Substance For Early Clinical Phase Initiation
5/6/2026
Explore how proactive nitrosamine impurity risk assessment protects early clinical drug supply, minimizes development delays, and enables confident progression to first‑in‑human studies.
-
Late‑Stage Progress In Excipients For Precision Nanomedicine
5/6/2026
View late‑stage development and GMP manufacturing of novel excipients for nanomedicines, emphasizing regulatory rigor, process optimization, analytics, and scale‑up for lipid‑based delivery systems.
-
Why Pharmaceutical Scientists Trust The Discovery Core Rheometer
5/1/2026
Drug formulations demand more than single‑point viscosity data. Explore how rheology reveals stability, flow, and structural behavior across suspensions, topicals, and injectables.
-
Bispecific T- Cell Engager (BiTE) Screening, Automated Pipeline
5/1/2026
View automated, high‑throughput BiTE screening in mammalian cells, enabling rapid discovery of efficacious variants through precise genomic integration and scalable workflows.
-
De-Risk Nucleic Acid Therapeutics Through Strategic Outsourcing
4/20/2026
Bringing a nucleic acid therapy to market requires specialized formulation and development knowledge. Innovators need rigorous analytical and formulation strategies to achieve stability and quality.